Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community‐Acquired Pneumonia Treated With Ceftaroline Fosamil-Reference-Cited by-同舟云学术

Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community‐Acquired Pneumonia Treated With Ceftaroline Fosamil

Published:2019-05 Issue: Volume: Page:
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Li Jianguo¹,Das Shampa²,Zhou Diansong¹,Al‐Huniti Nidal¹

Affiliation:

1. AstraZeneca Waltham MA USA

2. AstraZeneca Macclesfield UK

Funder

AstraZeneca

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.673

Reference32 articles.

1. Clinical and economic burden of community‐acquired pneumonia amongst adults in the Asia‐Pacific region;Song J‐H;Int J Antimicrob Agents,2011

2. FOCUS 1: a randomized, double‐blinded, multicentre, phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community‐acquired pneumonia;File TM;J Antimicrob Chemother,2011

3. FOCUS 2: a randomized, double‐blinded, multicentre, phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community‐acquired pneumonia;Low DE;J Antimicrob Chemother,2011

4. Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community‐acquired pneumonia: a randomised, controlled, double‐blind, phase 3, non‐inferiority with nested superiority trial;Zhong NS;Lancet Infect Dis,2015

5. Ceftaroline fosamil versus ceftriaxone for the treatment of community‐acquired pneumonia: individual patient data meta‐analysis of randomized controlled trials;Taboada M;J Antimicrob Chemother,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment;Clinical Pharmacokinetics;2023-11-26

2. Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistantStaphylococcus aureuspneumonia;European Respiratory Review;2023-10-18

3. Efficacy and Safety of Ceftaroline Fosamil in Hospitalized Patients with Community-Acquired Pneumonia in China: Subset Analysis of an International Phase 3 Randomized Controlled Trial;Infection and Drug Resistance;2022-02

4. The use of extrapolation based on modeling and simulation to support high‐dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft‐tissue infections;CPT: Pharmacometrics & Systems Pharmacology;2021-05

5. Pharmacokinetic and Pharmacodynamic Target Attainment in Adult and Pediatric Patients Following Administration of Ceftaroline Fosamil as a 5‐Minute Infusion;Clinical Pharmacology in Drug Development;2021-01-19